THE RELATIONSHIP OF SERUM SOLUBLE FAS LIGAND LEVEL (SFASL) WITH THE EXTEND OF CORONARY ARTERY DISEASE

被引：0
|
作者：
Sahinarslan, A. [1 ]
Boyaci, B. [1 ]
Kocaman, S. [1 ]
Okyay, K. [1 ]
Topal, S. [1 ]
Ercin, U. [2 ]
Bukan, N. [2 ]
Yalcin, R. [1 ]
Cengel, A. [1 ]
机构：
[1] Gazi Univ, Dept Cardiol, Ankara, Turkey
[2] Gazi Univ, Dept Biochem, Ankara, Turkey
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2011年 / 147卷
关键词：
D O I：
10.1016/S0167-5273(11)70181-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S61 / S62
页数：3
相关论文
共 50 条
  • [21] The levels of serum soluble Fas and soluble Fas ligand in retinoblastoma cases - Preliminary evaluation
    Cabi, Emel Unal
    Gunes, Meltem
    Vavuz, Gulsan
    Tacyildiz, Nurdan
    Ikincioguilari, Aydan
    Dogu, Figen
    Guloglu, Deniz
    Gunduz, Kaan
    Gunalp, Ilhan
    PEDIATRIC BLOOD & CANCER, 2007, 49 (04) : 538 - 538
  • [22] Soluble Fas ligand (sFasL) as a predictor of reduction of general psychopathology in schizophrenia after antipsychotic treatment
    Szymona, K.
    Karakula-Juchnowicz, H.
    Zdzisinska, B.
    Flis, M.
    Kalawaj, K.
    Rosa, W.
    Kandefer-Szerszen, M.
    EUROPEAN PSYCHIATRY, 2016, 33 : S108 - S108
  • [23] Severe malarial anemia associated with increased soluble Fas ligand (sFasL) concentrations in Gabonese children
    Issifou, S
    Mavoungou, E
    Borrmann, S
    Bouyou-Akotet, MK
    Matsiegui, PB
    Kremsner, PG
    Ntoumi, F
    EUROPEAN CYTOKINE NETWORK, 2003, 14 (04) : 238 - 241
  • [24] THE RELATIONSHIP BETWEEN SERUM URIC ACID LEVEL AND SEVERITY OF STABLE CORONARY ARTERY DISEASE
    Emet, Samim
    JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI, 2019, 82 (01): : 18 - 23
  • [25] Serum levels of soluble Fas ligand in patients with silicosis
    Tomokuni, A
    Otsuki, T
    Isozaki, Y
    Kita, S
    Ueki, H
    Kusaka, M
    Kishimoto, T
    Ueki, A
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1999, 118 (03): : 441 - 444
  • [26] Serum levels of soluble Fas and soluble Fas ligand in patients with primary biliary cirrhosis.
    Deguchi, A
    Arima, K
    Nishioka, M
    HEPATOLOGY, 1999, 30 (04) : 566A - 566A
  • [27] Prognostic Significance of Soluble Fas and Soluble Fas Ligand in Serum of Patients with Complete Hydatidiform Moles
    Soni, Simmi
    Rath, Gayatri
    Deval, Ravi
    Salhan, Sudha
    Mishra, Ashwini Kumar
    Saxena, Sunita
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2011, 66 (03) : 230 - 236
  • [28] The Relationship between the Serum NLRP1 Level and Coronary Lesions in Patients with Coronary Artery Disease
    Zong, Jing
    Wang, Yixiao
    Pan, Siyu
    Yang, Yiming
    Peng, Jingfeng
    Li, Fangfang
    Xu, Luhong
    Li, Shanshan
    Qian, Wenhao
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2023, 2023
  • [29] Detection of the soluble form of Fas ligand (sFasL) and sFas in the saliva from patients with Sjogren's syndrome
    Nakamura, H
    Kawakami, A
    Izumi, M
    Nakashima, T
    Takagi, Y
    Ida, H
    Nakamura, T
    Nakamura, T
    Eguchi, K
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2005, 23 (06) : 915 - 915
  • [30] Serum soluble Fas and Fas ligand (FasL) in primary Sjogren's syndrome
    Vincent, F. B.
    Bubicich, M.
    Downie-Doyle, S.
    Mackay, F.
    Morand, E.
    Rischmueller, M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 37 (03) : S254 - S256
12345